Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States.
Deitelzweig S, Guo JD, Hlavacek P, Lin J, Wygant G, Rosenblatt L, Gupta A, Pan X, Mardekian J, Lingohr-Smith M, Menges B, Marshall A, Nadkarni A. Deitelzweig S, et al. Among authors: hlavacek p. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):261S-268S. doi: 10.1177/1076029618800806. Epub 2018 Nov 15. Clin Appl Thromb Hemost. 2018. PMID: 30433823 Free PMC article.
All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants.
Deitelzweig S, Luo X, Gupta K, Trocio J, Mardekian J, Curtice T, Hlavacek P, Lingohr-Smith M, Menges B, Lin J. Deitelzweig S, et al. Among authors: hlavacek p. Clin Appl Thromb Hemost. 2018 May;24(4):602-611. doi: 10.1177/1076029617750269. Epub 2018 Jan 24. Clin Appl Thromb Hemost. 2018. PMID: 29363999 Free PMC article.
Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
Guo JD, Rajpura J, Hlavacek P, Keshishian A, Sah J, Delinger R, Mu Q, Mardekian J, Russ C, Okano GJ, Rosenblatt L. Guo JD, et al. Among authors: hlavacek p. J Manag Care Spec Pharm. 2020 Aug;26(8):1017-1026. doi: 10.18553/jmcp.2020.19311. Epub 2020 May 26. J Manag Care Spec Pharm. 2020. PMID: 32452277 Free PMC article.
Warfarin patients had significantly higher all-cause medical costs per patient per month (PPPM; $2,333 vs. $1,992; P = 0.001), MB-related costs PPPM ($112 vs. $65; P = 0.020), and recurrent VTE-related costs PPPM ($287 vs. $206; P = 0.014) compared with apixa …
Warfarin patients had significantly higher all-cause medical costs per patient per month (PPPM; $2,333 vs. $1,992; P = 0.001), MB-rel …
National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF) Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to PCPs.
Saeed H, Ovalle OG, Bokhary U, Jermihov A, Lepkowska K, Bauer V, Kuchta K, Wright M, Glosner S, Frazer M, Quintero A, Hlavacek P, Mardekian J, Tafur A, Metzl M, Saucedo J. Saeed H, et al. Among authors: hlavacek p. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952550. doi: 10.1177/1076029620952550. Clin Appl Thromb Hemost. 2020. PMID: 33079570 Free PMC article.
45 results